Literature DB >> 21126613

Prognostic effect of coronary flow reserve in women versus men with chest pain syndrome and normal dipyridamole stress echocardiography.

Lauro Cortigiani1, Fausto Rigo, Sonia Gherardi, Maurizio Galderisi, Francesco Bovenzi, Eugenio Picano, Rosa Sicari.   

Abstract

The aim of this study was to investigate the prognostic effect of coronary flow reserve (CFR) on left anterior descending artery (LAD) in women and men with chest pain of unknown origin and normal stress echocardiogram. The study population consisted of 1,660 patients (906 women, 754 men) with chest pain syndrome, no wall motion abnormality on echocardiogram at rest, and dipyridamole (up to 0.84 mg/kg over 6 minutes) stress echocardiogram negative for wall motion criteria. All had undergone stress echocardiography with combined evaluation of CFR on LAD by Doppler. A CFR value ≤2.0 was considered abnormal. Median duration of follow-up was 19 months (interquartile range 10 to 34). Abnormal CFR was assessed in 171 women (19%) and 147 men (19%, p = 0.80). During follow-up, 80 events (20 deaths, 13 ST-elevation myocardial infarctions, and 47 non-ST-elevation myocardial infarctions) occurred. In addition, 128 patients underwent revascularization and were censored. CFR ≤2.0 on LAD was independently associated with prognosis in women (hazard ratio [HR] 16.48, 95% confidence interval [CI] 7.17 to 37.85, p <0.0001) and in men (HR 6.23, 95% CI 3.42 to 11.33, p <0.0001). Antianginal therapy at time of testing (HR 2.11, 95% CI 1.14 to 3.90, p = 0.02) was also a multivariable prognostic predictor in men. Four-year event rate associated with CFR values ≤2.0 and >2.0 were, respectively, 27% and 2% in women (p <0.0001) and 42% and 8% in men (p <0.0001). In conclusion, decreased CFR on LAD is associated with markedly increased risk in women and men with chest pain syndrome and a normal result of dipyridamole stress echocardiography. Conversely, preserved CFR on LAD predicts excellent survival, particularly in women.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126613     DOI: 10.1016/j.amjcard.2010.08.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Coronary microvascular dysfunction: mechanisms and functional assessment.

Authors:  Paolo G Camici; Giulia d'Amati; Ornella Rimoldi
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

2.  Catheter-based functional metrics of the coronary circulation.

Authors:  Panagiotis Xaplanteris; Emanuele Barbato; Bernard De Bruyne
Journal:  J Nucl Cardiol       Date:  2016-09-07       Impact factor: 5.952

Review 3.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

Authors:  C Noel Bairey Merz; Carl J Pepine; Mary Norine Walsh; Jerome L Fleg
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

Review 4.  Coronary Flow Velocity Reserve Assessment with Transthoracic Doppler Echocardiography.

Authors:  Iana Simova
Journal:  Eur Cardiol       Date:  2015-07

Review 5.  Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease).

Authors:  Christine Pacheco Claudio; Odayme Quesada; Carl J Pepine; C Noel Bairey Merz
Journal:  Clin Cardiol       Date:  2018-03-02       Impact factor: 2.882

Review 6.  Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.

Authors:  Puja K Mehta; Odayme Quesada; Ahmed Al-Badri; Jerome L Fleg; Annabelle Santos Volgman; Carl J Pepine; C Noel Bairey Merz; Leslee J Shaw
Journal:  Int J Cardiol       Date:  2021-12-11       Impact factor: 4.164

Review 7.  Myocardial perfusion echocardiography and coronary microvascular dysfunction.

Authors:  Giuseppe Barletta; Maria Riccarda Del Bene
Journal:  World J Cardiol       Date:  2015-12-26

8.  Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.

Authors:  Yuhei Kobayashi; William F Fearon; Yasuhiro Honda; Shigemitsu Tanaka; Vedant Pargaonkar; Peter J Fitzgerald; David P Lee; Marcia Stefanick; Alan C Yeung; Jennifer A Tremmel
Journal:  JACC Cardiovasc Interv       Date:  2015-09       Impact factor: 11.195

9.  Coronary microvascular function and myocardial fibrosis in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study.

Authors:  Naja Dam Mygind; Marie Mide Michelsen; Adam Pena; Abbas Ali Qayyum; Daria Frestad; Thomas Emil Christensen; Adam Ali Ghotbi; Nynne Dose; Rebekka Faber; Niels Vejlstrup; Philip Hasbak; Andreas Kjaer; Eva Prescott; Jens Kastrup
Journal:  J Cardiovasc Magn Reson       Date:  2016-11-04       Impact factor: 5.364

10.  Transthoracic measurement of left coronary artery flow reserve improves the diagnostic value of routine dipyridamole-atropine stress echocardiogram.

Authors:  Jarosław D Kasprzak; Paulina Wejner-Mik; Aria Nouri; Ewa Szymczyk; Maria Krzemińska-Pakuła; Piotr Lipiec
Journal:  Arch Med Sci       Date:  2013-11-05       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.